title: Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation.
abstract: Epigenetics encompasses transient and heritable modifications to DNA and nucleosomes in the native chromatin context. For example, enzymatic addition of chemical moieties to the N-terminal "tails" of histones, particularly acetylation and methylation of lysine residues in the histone tails of H3 and H4, plays a key role in regulation of gene transcription. The modified histones, which are physically associated with gene regulatory regions that typically occur within conserved noncoding sequences, play a functional role in active, poised, or repressed gene transcription. The "histone code" defined by these modifications, along with the chromatin-binding acetylases, deacetylases, methylases, demethylases, and other enzymes that direct modifications resulting in specific patterns of histone modification, shows considerable evolutionary conservation from yeast to humans. Direct modifications at the DNA level, such as cytosine methylation at CpG motifs that represses promoter activity, are another highly conserved epigenetic mechanism of gene regulation. Furthermore, epigenetic modifications at the nucleosome or DNA level can also be coupled with higher-order intra- or interchromosomal interactions that influence the location of regulatory elements and that can place them in an environment of specific nucleoprotein complexes associated with transcription. In the mammalian immune system, epigenetic gene regulation is a crucial mechanism for a range of physiological processes, including the innate host immune response to pathogens and T cell differentiation driven by specific patterns of cytokine gene expression. Here, we will review current findings regarding epigenetic regulation of cytokine genes important in innate and/or adaptive immune responses, with a special focus upon the tumor necrosis factor/lymphotoxin locus and cytokine-driven CD4+ T cell differentiation into the Th1, Th2, and Th17 lineages.
authors.affiliation: Program in Cellular and Molecular Medicine at Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA. james.falvo@childrens.harvard.edu
authors.forename: James V
authors.initials: JV
authors.lastname: Falvo
authors.forename: Luke D
authors.initials: LD
authors.lastname: Jasenosky
authors.forename: Laurens
authors.initials: L
authors.lastname: Kruidenier
authors.forename: Anne E
authors.initials: AE
authors.lastname: Goldfeld
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics*; D044127:Epigenesis, Genetic / Q000235:genetics* / Q000276:immunology*; D063185:Epigenetic Repression; D005786:Gene Expression Regulation / Q000276:immunology*; D056426:Genetic Loci / Q000276:immunology; D006801:Humans; D008233:Lymphotoxin-alpha / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D006377:T-Lymphocytes, Helper-Inducer / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism
chemical_list: D016207:Cytokines; D008233:Lymphotoxin-alpha; D014409:Tumor Necrosis Factor-alpha